Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 16, 2023
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-15$0.46/sh+4,863$2,232→ 38,747 total
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.